Promakhos Therapeutics
Pagliuca Harvard Life Lab
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
Founders
Katerina Chatzi
Harvard Kenneth C. Griffin Graduate School of Arts & Sciences, Harvard Medical School
Jasper Neggers
Harvard Medical School
About Promakhos Therapeutics
School
Harvard Kenneth C. Griffin Graduate School of Arts & Sciences, Harvard Medical School
Promakhos Therapeutics is developing cures for autoimmune diseases. Millions of people suffer from autoimmunity, yet there is currently no cure. Existing treatments focus on blocking the immune system to manage symptoms, often providing temporary relief. In contrast, Promakhos addresses the root cause of the problem. We aspire to deliver curative therapies by developing treatments inspired by the body's resident bacteria. These treatments aim to modulate humans’ innate ability to resolve inflammation and promote healing.